Expert Recommendations and Global Practice Patterns From 2012-2015: Results From an Annually Updated Online Decision Aid for Multiple Myeloma (MM)

This poster was presented in December 2015 at the 57th American Society of Hematology annual meeting in Orlando, Florida. The poster highlights trends in expert treatment recommendations and practice patterns of clinicians who used an innovative online treatment decision tool for multiple myeloma between 2012 and 2015. In 2015, large numbers of clinicians chose treatment options that were not selected by the experts in the setting of induction therapy, 51% for transplant-eligible and 44% for transplant-ineligible patient scenarios, and in the setting of relapsed/refractory disease – 70%. Clinicians indicated that this tool would influence their treatment choice in 68% of cases, indicating a substantial impact on clinical decision making.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings